Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Sweden’s HealthCap invests in new radiotherapy company

Country: Sweden

Sweden-based venture capital fund HealthCap has provided funds to a new company that is developing alpha-particle emitting radiotherapeutics for cancer. Fusion Pharmaceuticals of Canada has raised $25 million in a Series A financing round.

Read more

Ablynx has higher revenue, operating loss

Country: Belgium

Ablynx NV, which has a portfolio of therapeutic proteins derived from the llama, reported a 10% increase in revenue to €85.2 million for 2016, but a wider operating loss of €28.6 million mainly due to higher clinical research expenses.

Read more

Robust growth at UCB

Country: Belgium

Read more

Genmab reports 60% higher revenue in 2016

Country: Denmark

Read more

FDA approves new psoriasis drug

Country: United States

Read more

Meeting Report: transparency in clinical trials

Country: Belgium

Read more

Shire’s results magnified by Baxalta purchase

Country: Ireland

Read more

Chimeric organs described

Country: United States

Read more

Another Alzheimer’s failure

Country: United States

Read more

Actelion produces sizzling annual results

Country: Switzerland

Read more

Monitoring immuno-oncology

Country: Germany

Read more

Meeting report: sifting the wheat from the chaff

Country: United Kingdom

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Bringing exhausted T cells back from the brink

T cell exhaustion StephenTurnerFeb2017.pdf

Highlights of the February 2017 MedNous issue

The February 2017 MedNous features:

Latest Mednous cover
  • Research Strategy
    Bringing exhausted T cells
    back from the brink
    By Stephen J. Turner
  • The Inventive Step
    How Keytruda was discovered
    Interview with Dutch scientists
  • Commentary
    Protein scaffolds come of age
    By Alastair Smith
  • Regenerative Medicine
    The challenges of cell therapy manufacture
    By Philip Vanek
  • Company Financing
    Novo A/S becomes strategic shareholder in Evotec
  • Clinical Research
    Another Alzheimer’s drug fails

The latest MedNous journal. Subscribe to download.